[1] HENDERSON D A.The eradication of smallpox——An overview of the past,present,and future[J]. Vaccine,2011,29(12):D7-D9.
[2] HALL A.The global eradication of smallpox.Final report of the global commission for the certification of smallpoxeradication[J]. Postgraduate Medical Journal, 1980,58(685):1.
[3] ANTOINE G,SCHEIFLINGER F,DORNER F,et al.The complete genomic sequence of the modified vaccinia Ankara strain:Comparison with other orthopoxviruses[J]. Virology, 1998,244(2):365-396.
[4] MEYER H,SUTTER G,MAYR A.Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence[J]. Journal of General Virology,1991,72(5):1031-1038.
[5] VOLZ A,SUTTER G.Modified vaccinia virus Ankara:History,value in basic research,and current perspectives for vaccine development[J]. Advances in Virus Research, 2017,97:187-243.
[6] EADY C C,WELD R J,LISTER C E.Agrobacterium tumefaciens-mediated transformation and transgenic-plant regeneration of onion (Allium cepa L.)[J]. Plant Cell Reports, 2000,19(4):376-381.
[7] GUBIN A,REDDY B,MILLER J.Long-term,stable expression of green fluorescent protein in mammalian cells[J]. Biochemical & Biophysical Research Communications, 1997,236(2):347-350.
[8] RADE J J,CHEUNG M,MIYAMOTO S,et al.Retroviral vector-mediated expression of hirudin by human vascular endothelial cells:Implications for the design of retroviral vectors expressing biologically active proteins[J]. Gene Therapy, 1999,6(3):385-392.
[9] CHALFIE M,TU Y,EUSKIRCHEN G,et al.Green fluorescent protein as a marker for gene expression[J]. Science, 1994,263(5148):802-805.
[10] ARNIM A G V,DENG X W,STACEY M G.Cloning vectors for the expression of green fluorescent protein fusion proteins in transgenic plants[J]. Gene,1998,221(1):35-43.
[11] VAN DER GEEST A H M,PETOLINO J F.Expression of a modified green fluorescent protein gene in transgenic maize plants and progeny[J]. Plant Cell Reports, 1998,17(10):760-764.
[12] ZHANG H X,ZEEVAART J A D.An efficient Agrobacterium tumefaciens -mediated transformation and regeneration system for cotyledons of spinach (Spinacia oleracea L.)[J]. Plant Cell Reports, 1999,18(7-8):640-645.
[13] PONAPPA T,BRZOZOWSKI A E,FINER J J.Transient expression and stable transformation of soybean using the jellyfish green fluorescent protein[J]. Plant Cell Reports, 1999,19(1):6-12.
[14] YOSHIMIZU T,SUGIYAMA N,DE F M,et al.Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice[J]. Development Growth & Differentiation, 2010,41(6):675-684.
[15] JONES C A,HURLEY M I,BLACK T A,et al.Expression of a renin/GFP transgene in mouse embryonic,extra-embryonic,and adult tissues[J]. Physiological Genomics, 2000,4(1):75-81.
[16] GONG Z,JU B,WAN H.Green fluorescent protein (GFP) transgenic fish and their applications[J]. Genetica, 2001,111(1-3):213-225.
[17] SEITA Y,TSUKIYAMA T,IWATANI C,et al.Generation of transgenic cynomolgus monkeys that express green fluorescent protein throughout the whole body[J]. Scientific Reports, 2016,6:24868.
[18] BORRÁS T,GABELT B T,KLINTWORTH G K,et al.Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo[J]. Journal of Gene Medicine, 2001,3(5):437-449.
[19] ISHIDA Y,SAITO H S,HIEI Y,et al.High efficiency transformation of maize (Zea mays L.) mediated by Agrobacterium tumefaciens[J]. Nature Biotechnology, 1996,14(6):745-750.
[20] CASPER S J,HOLT C A.Expression of the green fluorescent protein-encoding gene from a tobacco mosaic virus-based vector[J]. Gene, 1996,173(1):69-73.
[21] CRUZ S S,CHAPMAN S,ROBERTS A G,et al.Assembly and movement of a plant virus carrying a green fluorescent protein overcoat[J]. Proceedings of the National Academy of Sciences of the United States of America, 1996,93(13):6286-6290.
[22] STRIEPEN B,HE C,SOLDATI M,et al.Expression,selection,and organellar targeting of the green fluorescent protein in Toxoplasma gondii[J]. Molecular and Biochemical Parasitology, 1998,92(2):325-338.
[23] HA D S,SCHWARZ J K,TURCO S J,et al.Use of the green fluorescent protein as a marker in transfected Leishmania[J]. Molecular and Biochemical Parasitology, 1996,77(1):57-64.
[24] ORTIN-MARTINEZ A,TSAI E L,NICKERSON P E,et al.A reinterpretation of cell transplantation:GFP transfer from donor to host photoreceptors[J]. Stem Cells, 2017,35:932-939.
[25] CAMPBELL A S,PLOETZ R C,ROLLINS J A.Comparing avocado,swamp bay,and camphortree as hosts of Raffaelea lauricola using a green fluorescent protein (GFP)-labeled strain of the pathogen[J]. Phytopathology, 2017,107(1):70-74.
[26] 李吉霞,葛秀国,王轶敏,等.绿色荧光蛋白标记牛乳腺上皮细胞生长特征和超微结构观察[J].中国畜牧兽医,2013,40(5):115-119. LI J X,GE X G,WANG Y M,et al.Observation of growth characteristics and ultrastructure in GFP-labeled bovine mammary epithelialcells[J]. China Animal Husbandry & Veterinary Medicine,2013,40(5):115-119.(in Chinese)
[27] 刘翠,殷相平.携带 GFP 基因的重组狂犬病病毒的拯救及其生物学特性研究[J].中国畜牧兽医,2018,45(7):1965-1971. LIU C,YIN X P.Rescue and biological characteristics analysis of recombinant rabies virus containing GFP gene[J]. China Animal Husbandry & Veterinary Medicine,2018,45(7):1965-1971.(in Chinese)
[28] WALSH E P,BARON M D,ANDERSON J,et al.Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein[J]. Journal of General Virology, 2000,81(3):709-718.
[29] WALSH E P,BARON M D,RENNIE L F,et al.Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers:Evidence of exclusion of marker protein from the virus envelope[J]. Journal of Virology, 2000,74(21):10165-10175.
[30] JAHRLING P B,FRITZ E A,HENSLEY L E.Countermeasures to the bioterrorist threat of smallpox[J]. Current Molecular Medicine, 2005,5(8):817-826.
[31] SLIVA K,SCHNIERLE B.From actually toxic to highly specific——Novel drugs against poxviruses[J]. Virology Journal, 2007,4:8.
[32] VOIGT E A,KENNEDY R B,POLAND G A.Defending against smallpox:A focus on vaccines[J]. Expert Review of Vaccines, 2016,15(9):1197-1211.
[33] REYNOLDS M G,DAVIDSON W B,CURNS A T,et al.Spectrum of infection and risk factors for human Monkeypox,United States,2003[J]. Emerging Infectious Diseases, 2007,13(9):1332-1339.
[34] JACKSON R,RAMSHAW I.The mousepox experience[J]. EMBO Reports, 2010,11(1):18-24.
[35] PAOLETTI E,LIPINSKAS B R,SAMSONOFF C,et al.Construction of live vaccines using genetically engineered poxviruses:Biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D[J]. Proceedings of the National Academy of Sciences of the United States of America, 1984,81(1):193-197.
[36] SMITH G L,MACKETT M,MOSS B.Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen[J]. Nature, 1983,302(5908):490-495.
[37] BENNINK J R,YEWDELL J W,SMITH G L,et al.Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells[J]. Nature, 1984,311(5986):578-579.
[38] WINSLOW R L,MILLIGAN I D,VOYSEY M,et al.Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year[J]. The Journal of American Medical Association,2017,317(10):1075-1077.
[39] DOMI A,FELDMANN F,BASU R,et al.A single dose of modified vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge[J]. Scientific Reports, 2018,8(1):864.
[40] JULANDER J G,TESTORI M,CHEMINAY C,et al.Immunogenicity and protection after vaccination with a modified vaccinia virus Ankara-vectored yellow fever vaccine in the hamster model[J]. Frontiers in Immunology, 2018,9:1756.
[41] MACKETT M,SMITH G L,MOSS B.Vaccinia virus:A selectable eukaryotic cloning and expression vector[J]. Proceedings of the National Academy of Sciences,1982,79(23):7415-7419.
[42] PANICALI D,PAOLETTI E.Construction of poxviruses as cloning vectors:Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus[J]. Proceedings of the National Academy of Sciences of the United States of America,1982,79(16):4927-4931.
[43] BLANCOU J,KIENY M P,LATHE R,et al.Oral vaccination of the fox against rabies using a live recombinant vaccinia virus[J]. Nature,1986,322(6077):373-375.
[44] STAIB C,DREXLER I,SUTTER G.Construction and isolation of recombinant MVA[J]. Methods in Molecular Biology,2004,269:77-100.
[45] KREIJTZ J H,GOEIJENBIER M,MOESKER F M,et al.Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine:A randomised,double-blind phase 1/2a clinical trial[J]. The Lancet Infectious Diseases,2014,14(12):1196-1207.
[46] VOLZ A,LIM S,KASERER M,et al.Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens[J]. Vaccine,2016,34(16):1915-1926.
[47] XIAO Y L,REDMAN J C,MONAGHAN E L,et al.High throughput generation of promoter reporter (GFP) transgenic lines of low expressing genes in Arabidopsis and analysis of their expression patterns[J]. Plant Methods, 2010,6(1):18.
[48] HASHIMOTO H,MIZUSHIMA T,CHIJIWA T,et al.Efficient production of recombinant adeno-associated viral vector,serotype DJ/8,carrying the GFP gene[J]. Virus Research,2017,238:63-68.
[49] DE JONG J,HOFIUS D,HENNIG L.Salicylic acid interferes with GFP fluorescence in vivo[J]. Journal of Experimental Botany, 2017,68(7):1689-1696.
[50] CHOI J Y,JANG T H,PARK H H.The mechanism of folding robustness revealed by the crystal structure of extra-superfolder GFP[J]. FEBS Letters, 2017,591(2):442-447.
[51] GMEZ C E,PERDIGUERO B,GARCÍA-ARRIAZA J,et al.Clinical applications of attenuated MVA poxvirus strain[J]. Expert Review of Vaccines, 2013,12(12):1395-1416. |